MP

Melissa Pink

Director, Translational Pharmacology at Korro Bio

Melissa Pink has extensive work experience in the field of pharmacology, spanning over 25 years.

Melissa is currently employed as the Director of Translational Pharmacology at Korro Bio, Inc., a position they have held since December 2020.

Before joining Korro Bio, Inc., Melissa worked at Intellia Therapeutics, Inc. for 4 years as an Associate Director. In this role, they had various responsibilities, including preparing and reviewing documents for regulatory submissions, managing non-GLP safety pharmacology and DMPK studies, and planning and implementing biomarkers for clinical trials. Melissa also played a key role in evaluating new targets and disease areas, as well as maintaining collaborations with external partners and academic institutions. Additionally, they managed a team of 4 scientists.

Prior to their time at Intellia Therapeutics, Melissa held several positions at Infinity Pharmaceuticals, starting as a Research Investigator in Pharmacology in 2005. Melissa eventually progressed to the role of Senior Manager, with responsibilities such as studying target validation, efficacy, MOA, and PK/PD. Melissa also served as a Manager and Scientist during their tenure at the company.

Melissa began their career at Alkermes as a Research Associate in Pharmacology. In this role, they conducted investigations on a compound related to increasing the permeability of the blood-brain barrier and contributed to the development of a lung tumor model. Melissa also performed various experimental techniques related to autoradiography and behavioral studies.

Melissa's earliest work experience was at Millenium Pharmaceuticals, where they worked as a Research Associate in Cancer Pharmacology.

Overall, Melissa Pink has a diverse and comprehensive background in pharmacology, with experience in various roles and responsibilities across multiple companies.

Melissa Pink's education history includes attendance at Northeastern University. However, no information is available regarding the specific degree or field of study they pursued or the duration of their enrollment.

Links

Previous companies

Alkermes logo

Org chart

Timeline

  • Director, Translational Pharmacology

    December, 2020 - present

View in org chart